We found that treatment of mice with a Syk inhibitor led to a significant reduction in liver injury, as demonstrated by histopathology and alteration in serum ALT levels between Syk inhibitor plus lupus IgG treated group of C57BL/6 mice and the lupus IgG only treated group (Figure 5F). This evidence concerns the gene GPT and systemic lupus erythematosus.